| human | Q5 |
| P1960 | Google Scholar author ID | qVl73CAAAAAJ |
| P549 | Mathematics Genealogy Project ID | 52798 |
| P4955 | MR Author ID | 259955 |
| P496 | ORCID iD | 0000-0002-1383-6865 |
| P1153 | Scopus author ID | 7004537298 |
| P1556 | zbMATH author ID | kepler.thomas-b |
| P184 | doctoral advisor | Larry Abbott | Q19938073 |
| P185 | doctoral student | Michael D. Radmacher | Q102222513 |
| Lindsay Grey Cowell | Q102252333 | ||
| P69 | educated at | Brandeis University | Q49119 |
| P108 | employer | Boston University School of Medicine | Q4119659 |
| P734 | family name | Kepler | Q16277846 |
| Kepler | Q16277846 | ||
| Kepler | Q16277846 | ||
| P735 | given name | Budd | Q16274762 |
| Budd | Q16274762 | ||
| Thomas | Q16428906 | ||
| Thomas | Q16428906 | ||
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P106 | occupation | microbiologist | Q3779582 |
| neuroscientist | Q6337803 | ||
| P21 | sex or gender | male | Q6581097 |
| Q58045295 | A Bayesian approach for estimating calibration curves and unknown concentrations in immunoassays |
| Q42027962 | A Bayesian approach for estimating calibration curves and unknown concentrations in immunoassays |
| Q58045346 | A linear two-state model with complex dynamics |
| Q41877244 | A model for migratory B cell oscillations from receptor down-regulation induced by external chemokine fields |
| Q33952210 | A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza |
| Q34207773 | Advantage of rare HLA supertype in HIV disease progression |
| Q27684503 | Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains |
| Q37363517 | Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity |
| Q42184951 | Amino acid biophysical properties in the statistical prediction of peptide-MHC class I binding. |
| Q37680009 | An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. |
| Q47824025 | An information-theoretic method for the treatment of plural ancestry in phylogenetics. |
| Q35382871 | Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors |
| Q35487441 | Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization |
| Q35073270 | Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved |
| Q34273373 | B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study |
| Q58045299 | Bayesian Spatio-Dynamic Modeling in Cell Motility Studies: Learning Nonlinear Taxic Fields Guiding the Immune Response |
| Q36290038 | Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. |
| Q27671619 | Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin |
| Q33642157 | Chiropteran types I and II interferon genes inferred from genome sequencing traces by a statistical gene-family assembler |
| Q36491949 | Classification of osteoarthritis biomarkers: a proposed approach. |
| Q27644501 | Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus |
| Q37107609 | Comparison of multiple vaccine vectors in a single heterologous prime-boost trial |
| Q34114798 | Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies |
| Q91605118 | Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies |
| Q44869273 | Density-dependent prenatal androgen exposure as an endogenous mechanism for the generation of cycles in small mammal populations |
| Q38959483 | Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation |
| Q47213776 | Diversification of Ig superfamily genes in an invertebrate |
| Q36312295 | Drug concentration heterogeneity facilitates the evolution of drug resistance. |
| Q44850209 | Enhanced evolvability in immunoglobulin V genes under somatic hypermutation |
| Q34016211 | Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies |
| Q28748487 | First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis |
| Q36740992 | Flow: Statistics, visualization and informatics for flow cytometry |
| Q42073528 | Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains |
| Q58045365 | Geometric phase shifts under adiabatic parameter changes in classical dissipative systems |
| Q28743596 | H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination |
| Q38631751 | HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques |
| Q40449984 | HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism. |
| Q35728947 | HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies |
| Q42939116 | High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies |
| Q45747345 | Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors |
| Q34324992 | Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies |
| Q24815096 | Identifying differential expression in multiple SAGE libraries: an overdispersed log-linear model approach |
| Q30382955 | Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site. |
| Q34177732 | Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies |
| Q44874966 | Improved inference of mutation rates: I. An integral representation for the Luria-Delbrück distribution |
| Q52067136 | Improved inference of mutation rates: II. Generalization of the Luria-Delbrück distribution for realistic cell-cycle time distributions. |
| Q33370669 | Improving peptide-MHC class I binding prediction for unbalanced datasets |
| Q60301098 | Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier |
| Q30395005 | Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain |
| Q35441583 | Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated |
| Q47118310 | Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations |
| Q37221575 | Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages |
| Q33664494 | Invertebrate immune systems--not homogeneous, not simple, not well understood |
| Q90503791 | Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields |
| Q34042758 | Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting |
| Q41669208 | Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage |
| Q42029789 | Large-scale analysis of human heavy chain V(D)J recombination patterns |
| Q53634878 | Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. |
| Q27644415 | Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody |
| Q51621282 | Measurement of cell migration on surface-bound fibronectin gradients. |
| Q33802408 | Metastasizing patent claims on BRCA1 |
| Q40290511 | Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. |
| Q34323976 | Mixtures of Gaussian Wells: Theory, Computation, and Application |
| Q33958359 | Modeling and optimization of populations subject to time-dependent mutation |
| Q28572290 | Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells |
| Q51985457 | Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. |
| Q90135569 | Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies |
| Q29307029 | Open Source Research — the Power of Us |
| Q46847940 | P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies |
| Q51603839 | Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection. |
| Q24814174 | Pathway level analysis of gene expression using singular value decomposition |
| Q44139795 | Patient socioeconomic status is an independent predictor of operative mortality |
| Q58045357 | Physiological Insights from Cellular and Network Models of the Stomatogastric Nervous System of Lobsters and Crabs |
| Q40092127 | Potent and broad HIV-neutralizing antibodies in memory B cells and plasma |
| Q27675207 | Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody |
| Q44870111 | Predicted and inferred waiting times for key mutations in the germinal centre reaction: evidence for stochasticity in selection |
| Q36370482 | Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling |
| Q34892584 | Quantification of total T-cell receptor diversity by flow cytometry and spectratyping |
| Q44871622 | Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in rats |
| Q102210404 | Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth |
| Q38988188 | Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation |
| Q22337372 | Reduction of conductance-based neuron models |
| Q58045303 | Rejoinder |
| Q41910605 | Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II. |
| Q24678401 | Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants |
| Q36738008 | Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage |
| Q30495004 | Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants |
| Q40118226 | Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies |
| Q58045331 | Similar CD19 Dysregulation in Two Autoantibody-Associated Autoimmune Diseases Suggests a Shared Mechanism of B-Cell Tolerance Loss |
| Q39783279 | SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements |
| Q33229588 | SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations |
| Q52390653 | Somatic hypermutation in B cells: an optimal control treatment. |
| Q30997115 | SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization |
| Q30497163 | Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence Histology |
| Q36762536 | Spatiotemporal programming of a simple inflammatory process |
| Q58045361 | Spike initiation and propagation on axons with slow inward currents |
| Q40290521 | Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. |
| Q30992040 | Statistical analysis of antigen receptor spectratype data |
| Q34420737 | Statistical inference of sequence-dependent mutation rates. |
| Q36446733 | Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site |
| Q40626878 | Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee |
| Q33922778 | Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen |
| Q47372228 | Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates |
| Q46690685 | The 185/333 gene family is a rapidly diversifying host-defense gene cluster in the purple sea urchin Strongylocentrotus purpuratus |
| Q36717764 | The Multiscale Systems Immunology project: software for cell-based immunological simulation |
| Q35132544 | The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. |
| Q33466761 | The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly |
| Q33844333 | Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice |
| Q35868076 | Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design |
| Q31047702 | Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious |
| Q33612459 | Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates |
| Q27675879 | Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 |
| Q40955071 | Viral receptor-binding site antibodies with diverse germline origins |
| Q40198060 | Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop |
| Q43548521 | Waiting times to appearance and dominance of advantageous mutants: estimation based on the likelihood |
| Q48831166 | beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct |
| Q19938073 | Larry Abbott | doctoral student | P185 |
Search more.